Feature analysis on heart failure classes and associated medications

Heart failure (HF) is a major public health problem with an increasing prevalence that has tremendous impact to patients all over the world. However, the signs and symptoms of HF in the early stages are not clear, so it is relatively difficult to prevent or predict. HF is also one of complicated diseases, there are yet no strict standards to classify various types of HF patients based on various tendencies in each cause. To discover new evidences and associated medications for each type of HF according to some known features, we could divide HF patients into four major subgroups including systolic, diastolic, valvular, and non-specified types. We have performed statistical analysis and verified prediction results by several selected features for each clustered group from CGMH patient medical records. The constructed reference models could provide necessary measurements and prognosis indications for HF patients to prevent from heart deterioration. Based on automatic medication record analysis, we applied SVM tools to train and classify the associations for different HF types. The predicted results achieved an accuracy rate of 75.26% through a 10-folds cross validation mechanism. In addition, the proposed system effectively predicted patient's survival year and life expectancy with accuracy rates between 80%–87% under different parameter settings.

[1]  H. Calkins,et al.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2016, Journal of the American College of Cardiology.

[2]  W. Paulus,et al.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.

[3]  Hugh Calkins,et al.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2016, Circulation.

[4]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[5]  R. Lancashire,et al.  Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study , 2001, The Lancet.

[6]  A. Kengne,et al.  Prevalent diabetes mellitus in patients with heart failure and disease determinants in sub-Saharan Africans having diabetes with heart failure: a protocol for a systematic review and meta-analysis , 2016, BMJ Open.

[7]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[8]  M. Özdemir,et al.  [2014 European Society of Cardiology guidelines on hypertrophic cardiomyopathy]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[9]  K. Sliwa,et al.  Economic Burden of Heart Failure: Investigating Outpatient and Inpatient Costs in Abeokuta, Southwest Nigeria , 2014, PloS one.

[10]  Jun Yang,et al.  Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients , 2015, Experimental and therapeutic medicine.